Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States
Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-coun…
Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-coun…
Sanofi announces that it has successfully priced its offering of EUR 3 billion of notes across 3 tranches: EUR 1.0 bil…
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the Philippines have granted marketing approval to…